Cargando…

Improved Reagents for Newborn Screening of Mucopolysaccharidosis Types I, II, and VI by Tandem Mass Spectrometry

[Image: see text] Tandem mass spectrometry for the multiplex and quantitative analysis of enzyme activities in dried blood spots on newborn screening cards has emerged as a powerful technique for early assessment of lysosomal storage diseases. Here we report the design and process-scale synthesis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chennamaneni, Naveen Kumar, Kumar, Arun Babu, Barcenas, Mariana, Spáčil, Zdeněk, Scott, C. Ronald, Tureček, František, Gelb, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014144/ https://www.ncbi.nlm.nih.gov/pubmed/24694010 http://dx.doi.org/10.1021/ac5004135

Ejemplares similares

Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs
por: Gelb, Michael H., et al.
Publicado: (2017)

Tandem Mass Spectrometry Assays of Palmitoyl Protein Thioesterase 1 and Tripeptidyl Peptidase Activity in Dried Blood Spots for the Detection of Neuronal Ceroid Lipofuscinoses in Newborns
por: Barcenas, Mariana, et al.
Publicado: (2014)

Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry()
por: Elliott, Susan, et al.
Publicado: (2016)

Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometry
por: Elliott, Susan, et al.
Publicado: (2016)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Visual impairment in mucopolysaccharidosis VI
por: Magalhães, Augusto Monteiro, et al.
Publicado: (2023)

Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014)

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
por: Gelb, Michael H., et al.
Publicado: (2022)

ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry
por: Henry, Scott M., et al.
Publicado: (2017)

Diagnostic and treatment strategies in mucopolysaccharidosis VI
por: Vairo, Filippo, et al.
Publicado: (2015)

Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II
por: Wang, Junhua, et al.
Publicado: (2020)

Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI
por: Harmatz, Paul R., et al.
Publicado: (2013)

Vertebral Tongue-Like Deformity in Mucopolysaccharidosis VI
por: Landen, Michiel, et al.
Publicado: (2021)

Epidemiology and Genetics of Mucopolysaccharidosis Type VI in Russia
por: Voskoboeva, Elena, et al.
Publicado: (2022)

Mucopolysaccharidosis Type VI, an Updated Overview of the Disease
por: D’Avanzo, Francesca, et al.
Publicado: (2021)

Mucopolysaccharidosis Type VI with Recurrent Chest Infection
por: Numan, Ashraf, et al.
Publicado: (2023)

Mucopolysaccharidosis VI in cats – clarification regarding genetic testing
por: Lyons, Leslie A., et al.
Publicado: (2016)

Combined mucopolysaccharidosis type VI and congenital adrenal hyperplasia in a child: Anesthetic considerations
por: Bansal, Abhishek, et al.
Publicado: (2012)

Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment
por: Giugliani, Roberto, et al.
Publicado: (2010)

Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
por: Brands, Marion M, et al.
Publicado: (2013)

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
por: Karir, Aneesh, et al.
Publicado: (2018)

Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics
por: Tebani, Abdellah, et al.
Publicado: (2019)

The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
por: Herbst, Zackary M., et al.
Publicado: (2020)

Postanalytical tools improve performance of newborn screening by tandem mass spectrometry
por: Hall, Patricia L., et al.
Publicado: (2014)

An Easily Overlooked Contamination of Syringes in Newborn Screening by Tandem Mass Spectrometry
por: Wang, Yanyun, et al.
Publicado: (2021)

Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene
por: Tomanin, Rosella, et al.
Publicado: (2018)

Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
por: Burton, Barbara K., et al.
Publicado: (2020)

A case of mucopolysaccharidosis type VI in a polish family. Importance of genetic testing and genotype-phenotype relationship in the diagnosis of mucopolysaccharidosis
por: Zapała, Barbara, et al.
Publicado: (2020)

Newborn Sickle Cell Disease Screening Using Electrospray Tandem Mass Spectrometry
por: Daniel, Yvonne, et al.
Publicado: (2018)

Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry
por: Padilla, Carmencita D., et al.
Publicado: (2022)

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia
por: Pachajoa, Harry, et al.
Publicado: (2014)

Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux–Lamy syndrome)
por: Giraldo, Gustavo Adolfo, et al.
Publicado: (2015)

Respiratory Dysfunction in Children and Adolescents with Mucopolysaccharidosis Types I, II, IVA, and VI
por: Tulebayeva, Assel, et al.
Publicado: (2020)

Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in newborns from Xinxiang city in China
por: Ma, Shujun, et al.
Publicado: (2020)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
por: Herbst, Zackary M., et al.
Publicado: (2022)

Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

Identification of a frit-related sample carryover in newborn screening by tandem mass spectrometry
por: Kim, Kyunghun, et al.
Publicado: (2023)

Ethical and economic considerations of rare diseases in ethnic minorities: the case of mucopolysaccharidosis VI in Colombia
por: Rosselli, Diego, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8dfud57lp3m31jehfg8146ussc